Skip to main content
Year archive

BRAIN Biotech AG — 2023 filings

All 34 regulatory filings released by BRAIN Biotech AG (BNN) in 2023, sourced directly from the official regulator.

34 Filings
2023 Period
2023 filings (34)
Filing Released Lang
Akribion Genomics receives the Hessian Founder Award for its innovative approach to a new cancer therapy
Regulatory Filings
2023-11-20 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements
2023-10-30 German
BRAIN Biotech AG: BRAIN Biotech AG s Akribion Genomics team wins first prize at the BioRiver Boost! startup competition
Regulatory Filings
2023-09-28 English
BRAIN Biotech AG: BRAIN Biotech AGs Akribion Genomics technology receives patent approval for its groundbreaking nuclease G-dase E
Regulatory Filings
2023-09-14 English
BRAIN Biotech AG: Scientist from BRAIN Biotech AG receives VAAM Innovation Award for the discovery of a novel CRISPR nuclease family
Environmental & Social Information
2023-09-12 English
BRAIN Biotech AG reports solid 9M numbers despite ongoing high R&D investments and more challenging economic conditions
Earnings Release 9M 2023
2023-08-30 English
Q3 statement / Q3 financial report 2022/2023
Interim / Quarterly Report 9M 2023
2023-08-30 English
BRAIN Biotech AG s Akribion Genomics team successfully competes in Science4Life Venture Cup competition
Regulatory Filings
2023-06-28 English
Anniversary of BRAIN Biotech AG: 30 years for a bio-based future
Regulatory Filings
2023-06-19 English
BRAIN Biotech AG stays on solid growth path with H1 results and accelerates One-BioProducts strategy
Earnings Release H1 2023
2023-05-25 English
Halbjahresfinanzbericht nach WpHG für den Zeitraum vom 01.10.2022 bis zum 31.03.2023
Interim / Quarterly Report H1 2023
2023-05-25 German
Half-yearly financial report 2022/2023
Interim / Quarterly Report H2 2023
2023-05-25 English
BRAIN Biotech AG gains full ownership of Biocatalysts Ltd and accelerates execution of its One-BioProducts Strategy
M&A Activity
2023-05-24 English
Report Publication Announcement 2023
Report Publication Announcement
2023-05-17 English
Hinweis auf Halbjahresfinanzbericht vom 01.10.2022 bis zum 31.03.2023
Report Publication Announcement
2023-05-17 German
Hinweis auf Halbjahresfinanzbericht vom 01.10.2022 bis zum 31.03.2023
Report Publication Announcement
2023-05-17 German
BRAIN Biotech AG: Dr. Michael Majerus, buy
Director's Dealing
2023-04-20 English
Resolutions of the Annual General Meeting 2023 on the Financial Year 2021/2022 of BRAIN Biotech AG
AGM Information
2023-03-08 English
Capital Markets Day 2023: BRAIN Biotech AG to build an international multi-niche enzyme and food ingredients champion
Regulatory Filings
2023-02-27 English
BRAIN Biotech AG with Strong Start into Fiscal Year 2022/23, 3M Reporting
Earnings Release Q1 2022
2023-02-27 English
Q1 statement / Q1 financial report 2022/2023
Interim / Quarterly Report Q2 2023
2023-02-27 German
BRAIN Biotech and TransCode Therapeutics join forces to develop a CRISPR-derived technology platform for cancer treatment
Regulatory Filings
2023-02-22 English
BRAIN Biotech AG terminates contract for natural sweetener solution with Roquette Freres
Regulatory Filings
2023-02-10 English
Jahresabschluss zum Geschäftsjahr vom 01.10.2021 bis zum 30.09.2022
Interim / Quarterly Report FY 2022
2023-02-03 German
Konzernabschluss zum Geschäftsjahr vom 01.10.2021 bis zum 30.09.2022
Annual Report (ESEF) FY 2022
2023-02-03 German
BRAIN Biotech AG: Bekanntmachung der Einberufung zur Hauptversammlung am 08.03.2023 in Offenbach am Main mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2023-01-27 German
Annual financial report 2021/2022
Annual Report FY 2022
2023-01-17 English
BRAIN Biotech AG reports record figures in fiscal year 2021/22 despite challenging geopolitical environment
Earnings Release FY 2022
2023-01-16 English
BRAIN Biotech AG: BRAIN Group's Akribion Genomics business will prioritize the development of therapeutic applications within its CRISPR technology platform
Regulatory Filings
2023-01-10 English
BRAIN Biotech AG: prioritizing development of therapeutic applications of the Akribion Genomics technology platform (genome-editing)
Regulatory Filings
2023-01-10 English
Report Publication Announcement 2023
Report Publication Announcement
2023-01-09 English
BRAIN Biotech AG: Key Leadership Appointments at BRAIN Biotech AG, Zwingenberg Site
Board/Management Information
2023-01-09 English
Hinweis auf Jahresfinanzbericht vom 01.10.2021 bis zum 30.09.2022
Report Publication Announcement
2023-01-09 German
Hinweis auf Jahresfinanzbericht vom 01.10.2021 bis zum 30.09.2022
Report Publication Announcement
2023-01-09 German